[Dapsone-induced photodermatitis in a patient with leprosy].
We report on a 60-year-old man suffering from borderline leprosy. He was treated many times with DDS and Clofazimin and underwent the so-called multiple drug treatment (MDT). Under this therapy, the patient developed allergic photodermatitis. Unfortunately his file was lost and, as nobody was informed about his allergic reaction, he was again treated with the preparations mentioned above. Consequently, he responded once more with photodermatitis.
Fumey
S M
SM
National Leprosy Control Programme of Ethiopia Addis.
D003622:Dapsone / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010787:Photosensitivity Disorders / Q000139:chemically induced*
D003622:Dapsone
DDS-induzierte Photodermatitis bei einem Lepra-Patienten.